Below are the three companies in the Biotechnology industry with the highest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.
PDL BioPharma (NASDAQ:PDLI) is highest with an RPE of $46.8 million. PDL BioPharma Inc. discovers, develops, and markets therapies for serious or life-threatening illnesses, commercially focused on the acute care, hospital setting. Thus far today, PDL BioPharma has traded 355,000 shares, vs. average volume of 1.8 million shares per day. The stock has matched the Dow (with a -0.2% move) and underperformed the S&P 500 (-0.2% to the S&P's -0.1%) during today's trading.
Following is Gilead Sciences (NASDAQ:GILD) with an RPE of $2.4 million.
Finishing up the top three is Pharmacyclics (NASDAQ:PCYC), with an RPE of $2.1 million.